... lymphoma, was $477 million. That trailed analysts' estimates for about $500 million, according to Sanford C. Bernstein's Geoffrey Porges.

Gannett Co. slipped 43 cents to $58.39. First-qu ...

... '); } else { document.write(''); } } //--> Investor's Business Daily: Breaking News '); //-->

The seemingly tired, old bull market advanced in the fourth quarter as strong fundamentals ou ...

... NAMC Newswire - Nasdaq, NYSE Group, LSE, Genentech, Google, Abercrombie & Fitch, Las Vegas Sands, China Medical Tech

(c) NAMC Newswire Issuers of news releases and not NAMC are solely responsi ...

... CBC New Brunswick - Canadian Cancer Society pushing pesticide ban ...

... lymphoma drug Rituxan produced by daughter company Genentech.

Roche, which was founded in 1896 in Basel, has core businesses in pharmaceuticals and diagnostics.

The group is the number one ...

... ...

...

Wall Street still isn't doing back flips over biotech giant , despite the company's solid first-quarter profit report after Tuesday's closing bell.

A 39% jump in the company's stock price ...

... '); } else { document.write(''); } } //--> Investor's Business Daily: Breaking News '); //-->

The seemingly tired, old bull market advanced in the fourth quarter as strong fundamentals ou ...

... lymphoma, was $477 million. That trailed analysts' estimates for about $500 million, according to Sanford C. Bernstein's Geoffrey Porges.

Harley-Davidson Inc., the world's most profi ...

... '); } else { document.write(''); } } //--> Investor's Business Daily: Breaking News '); //-->

The seemingly tired, old bull market advanced in the fourth quarter as strong fundamentals ou ...